Cargando…

Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use

Detalles Bibliográficos
Autores principales: Edwards, Kathryn M., Orenstein, Walter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303663/
https://www.ncbi.nlm.nih.gov/pubmed/32565096
http://dx.doi.org/10.1016/j.jpeds.2020.06.048
_version_ 1783548107586273280
author Edwards, Kathryn M.
Orenstein, Walter A.
author_facet Edwards, Kathryn M.
Orenstein, Walter A.
author_sort Edwards, Kathryn M.
collection PubMed
description
format Online
Article
Text
id pubmed-7303663
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-73036632020-06-19 Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use Edwards, Kathryn M. Orenstein, Walter A. J Pediatr Commentary Elsevier Inc. 2020-09 2020-06-19 /pmc/articles/PMC7303663/ /pubmed/32565096 http://dx.doi.org/10.1016/j.jpeds.2020.06.048 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Edwards, Kathryn M.
Orenstein, Walter A.
Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use
title Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use
title_full Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use
title_fullStr Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use
title_full_unstemmed Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use
title_short Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use
title_sort anticipating severe acute respiratory syndrome coronavirus 2 vaccine testing, licensure, and recommendations for use
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303663/
https://www.ncbi.nlm.nih.gov/pubmed/32565096
http://dx.doi.org/10.1016/j.jpeds.2020.06.048
work_keys_str_mv AT edwardskathrynm anticipatingsevereacuterespiratorysyndromecoronavirus2vaccinetestinglicensureandrecommendationsforuse
AT orensteinwaltera anticipatingsevereacuterespiratorysyndromecoronavirus2vaccinetestinglicensureandrecommendationsforuse